(Q42250207)

English

Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection

scientific article published on 10 January 2014

Statements

Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection (English)
Thorsten Kirschberg
Melanie Cornpropst

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit